421
STRUCTURED CONTENT
Editorials and general subjects
Software is Eating the Clinic, J.L. Rees
423–424
Atopy, allergy and eczema
The Value of FLG Null Mutations in Predicting Treatment Response in Atopic Dermatitis: An Observational
Study in Finnish Patients, T. Maria Luukkonen, et al.
456–463
Itch, urticaria and neurodermatology
A Literature Review of Senile Pruritus: From Diagnosis to Treatment, C-J. Clerc and L. Misery
Paediatric Erythema Multiforme: Epidemiological, Clinical and Laboratory Characteristics, Y. Siedner-
Weintraub, et al.
Clinical Aspects of Itch in Lichen Planus, K. Welz-Kubiak, et al.
Nocturnal Pruritus: Prevalence, Characteristics, and Impact on ItchyQoL in a Chronic Itch Population, M.J.
Lavery, et al.
Follicular Traction Urticaria: A New Form of Chronic Inducible Urticaria?, N. Raison-Peyron, et al.
Treatment of Refractory Chronic Spontaneous Urticaria with Adalimumab, N. Bangsgaard, et al.
433–440
489–492
505–508
513–515
522–523
524–525
Psoriasis and autoimmune diseases
Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert
Meeting, L. Raaby, et al.
Overexpression of Psoriasin (S100A7) Contributes to Dysregulated Differentiation in Psoriasis, A-K. Ek-
man, et al.
Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of
the Inflammatory TNFα – IL-23 – IL-17 Axis, M.E. Kubin, et al.
Increased Activity and Apoptosis of Eosinophils in Blister Fluids, Skin and Peripheral Blood of Patients
with Bullous Pemphigoid, J. Engmann, et al.
Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis:
Evidence from the PSONET Registries, P. Davila-Seijo, et al.
Psoriatic Arthritis, but not Psoriasis, is Associated with Primary Adrenal Insufficiency, P. Jensen, et al.
Psoriasis as a Manifestation of an Immune Reconstitution in Two Patients with Hepatitis C Treated with
Ledipasvir/Sofosbuvir, F. Heppt and M. Sticherling
Linear IgA Bullous Dermatosis Associated with Immunoglobulin Light-chain Amyloidosis, Y. Yamaguchi,
et al.
426–432
441–448
449–455
464–471
516–518
519–521
526–527
528–529
Immunology, lymphoma and HIV/AIDS
Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of
the Inflammatory TNFα – IL-23 – IL-17 Axis, M.E. Kubin, et al.
Primary Cutaneous T-cell Lymphoma with Aberrant Expression of CD20, V.G. Frings, et al.
449–455
534–536
Drug development and adverse reactions
Development of Papulopustular Rosacea during Nivolumab Therapy for Metastatic Cancer, E. Bousquet, et al.
Psoriasis as a Manifestation of an Immune Reconstitution in Two Patients with Hepatitis C Treated with
Ledipasvir/Sofosbuvir, F. Heppt and M. Sticherling
539–540
526–527
Skin tumours and pigmentation
Clinical, Genetic and Innate Immunity Characteristics of Melanoma in Organ Transplant Recipients, A.
Brocard, et al.
Becker Naevus Syndrome of the Lower Body: One Case and Review of the Literature, K. Schäfer, et al.
Pigmented Intertriginous Lesions and Bullous Plaques: A Quiz, M. Zychowska, et al.
483–488
499–504
548–549
Hair, nails and adnexal disorders
Trichotillomania Among Young Adults: Prevalence and Comorbidity, M. Grzesiak, et al.
509–512
Inherited diseases and malformations
Becker Naevus Syndrome of the Lower Body: One Case and Review of the Literature, K. Schäfer, et al.
A Novel De novo Mutation of the SASH1 Gene in a Chinese Family with Multiple Lentigines, J. Wang, et al.
Congenital Ichthyosis and Recurrent Eczema Associated with a Novel ALOXE3 Mutation, T. Takeichi, et al.
499–504
530–531
532–533
Acta Derm Venereol 2017; 97: 421–422